[go: up one dir, main page]

DE69935721D1 - Kälte-adaptierte pferde influenza-viren - Google Patents

Kälte-adaptierte pferde influenza-viren

Info

Publication number
DE69935721D1
DE69935721D1 DE69935721T DE69935721T DE69935721D1 DE 69935721 D1 DE69935721 D1 DE 69935721D1 DE 69935721 T DE69935721 T DE 69935721T DE 69935721 T DE69935721 T DE 69935721T DE 69935721 D1 DE69935721 D1 DE 69935721D1
Authority
DE
Germany
Prior art keywords
virus
viruses
cold
equine influenza
influenza
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69935721T
Other languages
English (en)
Other versions
DE69935721T2 (de
Inventor
Patricia W Dowling
Julius S Youngner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pittsburgh
Original Assignee
University of Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pittsburgh filed Critical University of Pittsburgh
Application granted granted Critical
Publication of DE69935721D1 publication Critical patent/DE69935721D1/de
Publication of DE69935721T2 publication Critical patent/DE69935721T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation
    • C12N2760/16164—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69935721T 1998-08-13 1999-08-12 Kälteadaptierte Pferdeinfluenzaviren Expired - Lifetime DE69935721T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/133,921 US6177082B1 (en) 1998-08-13 1998-08-13 Cold-adapted equine influenza viruses
US133921 1998-08-13
PCT/US1999/018583 WO2000009702A1 (en) 1998-08-13 1999-08-12 Cold-adapted equine influenza viruses

Publications (2)

Publication Number Publication Date
DE69935721D1 true DE69935721D1 (de) 2007-05-16
DE69935721T2 DE69935721T2 (de) 2008-02-07

Family

ID=22460917

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69935721T Expired - Lifetime DE69935721T2 (de) 1998-08-13 1999-08-12 Kälteadaptierte Pferdeinfluenzaviren

Country Status (10)

Country Link
US (3) US6177082B1 (de)
EP (2) EP1105497B1 (de)
JP (3) JP4583602B2 (de)
AT (1) ATE358722T1 (de)
AU (1) AU760356B2 (de)
CA (1) CA2339089C (de)
DE (1) DE69935721T2 (de)
DK (1) DK1105497T3 (de)
ES (1) ES2286892T3 (de)
WO (1) WO2000009702A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9711389D0 (en) * 1997-06-04 1997-07-30 Univ Wales The Bacterial pheromones and uses therefor
US6482414B1 (en) * 1998-08-13 2002-11-19 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
US6177082B1 (en) 1998-08-13 2001-01-23 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
DE60125736D1 (de) * 2000-04-03 2007-02-15 Univ Pittsburgh Zusammensetzungen, die kälteangepasste pferdeinfluenzaviren enthaltende, für die behandlung von bestehende virusinfektionen des atmungssystems
JP2002153262A (ja) * 2000-11-20 2002-05-28 Shibuya Kogyo Co Ltd 鶏卵の処理方法および処理装置
US7923023B2 (en) * 2002-02-25 2011-04-12 Astech International LLC Method and composition for delivery of medicants to animals
CN103540613A (zh) * 2002-04-26 2014-01-29 米迪缪尼有限公司 制备流感病毒的多质粒系统
US7465456B2 (en) * 2002-04-26 2008-12-16 Medimmune, Llc Multi plasmid system for the production of influenza virus
US20060110406A1 (en) * 2003-02-25 2006-05-25 Medimmune Vaccines, Inc. Refrigerator-temperature stable influenza vaccine compositions
KR101190932B1 (ko) * 2003-02-25 2012-10-16 메디뮨 엘엘씨 인플루엔자 백신 조성물의 제조 방법
WO2005014778A2 (en) * 2003-05-15 2005-02-17 The Board Of Regents For Oklahoma State University Dna vaccine expressing ha1 of equine-2 influenza virus
ATE469972T1 (de) 2003-12-23 2010-06-15 Medimmune Llc Multiplasmid-system zur erzeugung des grippevirus
WO2006009821A1 (en) * 2004-06-17 2006-01-26 W5 Networks, Inc. Pseudo noise coded communication systems
US7572620B2 (en) 2005-01-11 2009-08-11 Wisconsin Alumni Research Foundation H3 equine influenza A virus
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
ES2570758T3 (es) * 2005-04-21 2016-05-20 Univ Florida Materiales y métodos para el control de enfermedades respiratorias en cánidos
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US20080241184A1 (en) * 2005-08-25 2008-10-02 Jules Maarten Minke Canine influenza vaccines
PH12011502633A1 (en) * 2005-10-07 2012-11-12 Zoetis P Llc Vaccines and methods to treat canine influenza
US7468187B2 (en) * 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
AU2013205112C1 (en) * 2005-10-19 2015-12-03 Cornell Research Foundation, Inc. Influenza viruses able to infect canids, uses thereof
KR101597534B1 (ko) * 2005-10-19 2016-02-26 유니버시티 오브 플로리다 리서치 파운데이션, 인크. 개과 동물의 호흡기 질병 조절을 위한 물질들 및 방법들
EP1779866A1 (de) 2005-11-01 2007-05-02 Intervet International BV "Prime-Boost" Impfstoff zum Schutz von Pferden vor viraler Infektion
CA2626875A1 (en) * 2005-11-01 2007-05-10 Intervet International B.V. Prime boost vaccine for the protection of equines against equine influenza
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
US8673613B2 (en) * 2007-06-18 2014-03-18 Medimmune, Llc Influenza B viruses having alterations in the hemaglutinin polypeptide
MX350718B (es) 2011-03-14 2017-09-14 Boehringer Ingelheim Vetmedica Inc Vacuna de rinitis equina.
KR101490292B1 (ko) 2012-04-16 2015-02-04 한국생명공학연구원 신규한 ｈ3ｎ8 말 인플루엔자 바이러스
JP2013099339A (ja) * 2013-01-04 2013-05-23 Wisconsin Alumni Research Foundation Ｈ３型ウマａ型インフルエンザウイルス
CN104436157A (zh) 2013-09-23 2015-03-25 恩金生物有限公司 流感疫苗和治疗
US10080792B2 (en) 2013-09-23 2018-09-25 Engen Bio, Inc. Influenza vaccine and therapy
WO2016083287A1 (en) 2014-11-24 2016-06-02 Intervet International B.V. Inactivated equine influenza virus vaccines
JP2023506304A (ja) 2019-12-18 2023-02-15 インターベット インターナショナル ベー． フェー． 経口呼吸器ワクチン

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3518347A (en) 1965-05-28 1970-06-30 Inst Microbiologie Et D Hygien Vaccine for equine influenza
US3992522A (en) * 1973-01-24 1976-11-16 The United States Of America As Represented By The Department Of Health, Education And Welfare Temperature-sensitive recombinant mutant viruses and a process for producing same
SE434346C (sv) * 1982-04-07 1985-10-28 Johann Haberl Cyklonavskiljare med filterenhet for avskiljning av stoff fran gas, varvid en veckad filterenhet er anordnad med en ringspalt mot avskiljarens centralror
EP0105364B1 (de) 1982-04-16 1990-03-28 Cornell Research Foundation, Inc. Temperaturempfindliche reassortierende viren und impfstoff gegen pferdeinfluenza
US4683137A (en) 1982-04-16 1987-07-28 Cornell Research Foundation, Inc. Temperature sensitive reassortant viruses and a vaccine against equine influenza
GB8300467D0 (en) 1983-01-08 1983-02-09 Wellcome Found Equine influenza
US4920213A (en) 1985-06-20 1990-04-24 Biotechnology Research Partners, Ltd. Method and compositions useful in preventing equine influenza
US4631191A (en) 1985-06-20 1986-12-23 Biotechnology Research Partners, Ltd. Methods and compositions useful in preventing equine influenza
US5149531A (en) 1990-06-27 1992-09-22 University Of Pittsburgh Of The Commonwealth System Of Higher Education Method of using cold-adapted live influenza virus vaccine as an antiviral agent against influenza
IL105456A (en) 1992-04-21 1996-12-05 American Home Prod Vaccines of attenuated respiratory syncytial virus
US5690937A (en) 1995-06-05 1997-11-25 Aviron Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene
US6177082B1 (en) 1998-08-13 2001-01-23 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses

Also Published As

Publication number Publication date
AU5487799A (en) 2000-03-06
US20030180322A1 (en) 2003-09-25
EP1105497B1 (de) 2007-04-04
EP1854886A2 (de) 2007-11-14
JP2009297040A (ja) 2009-12-24
DK1105497T3 (da) 2007-07-30
DE69935721T2 (de) 2008-02-07
EP1854886A3 (de) 2007-11-21
WO2000009702A1 (en) 2000-02-24
JP2012085657A (ja) 2012-05-10
EP1105497A1 (de) 2001-06-13
US6177082B1 (en) 2001-01-23
US6436408B1 (en) 2002-08-20
AU760356B2 (en) 2003-05-15
JP2002522078A (ja) 2002-07-23
JP5261338B2 (ja) 2013-08-14
CA2339089C (en) 2009-06-02
ES2286892T3 (es) 2007-12-01
CA2339089A1 (en) 2000-02-24
JP4583602B2 (ja) 2010-11-17
ATE358722T1 (de) 2007-04-15
US6649169B2 (en) 2003-11-18

Similar Documents

Publication Publication Date Title
ATE358722T1 (de) Kälte-adaptierte pferde influenza-viren
WO2001060849A3 (en) Cold-adapted equine influenza viruses
Wiktor Cell-mediated immunity and postexposure protection from rabies by inactivated vaccines of tissue culture origin
TW200730188A (en) Vaccines and methods to treat canine influenza
EA200500723A1 (ru) Соединения бензофурана, композиции и способы лечения и профилактики инфекций, вызванных вирусом гепатита c, и связанных с ним заболеваний
AU4930001A (en) Cold-adapted equine influenza viruses
CY1107188T1 (el) Εμβολιο ε. coli πτηνου για την προστασια εναντι κολοβακτηριωσης
MXPA02004627A (es) Vacunas contra el micoplasma bovis y sus metodos de uso.
ATE375804T1 (de) Ribavirin-enthaltende vakzine
JP2003528925A5 (de)
Dowling et al. Cold-adapted equine influenza viruses
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
WO2007135420A3 (en) Defective interfering virus
TW200503755A (en) Avian vaccine composition for the protection of poultry against disease and infection caused by e. coli and salmonella
NO20025898D0 (no) Fremgangsmåte for å öke overlevelsesraten til akvatiske dyr eksponert for en akvatisk virus og sammensetninger til bruk for slikefremgangsmåter
DK1132466T3 (da) Kyllingeanæmivira med lav patogenicitet
ATE39055T1 (de) Verfahren zur immunisierung von schweinen gegen die aujeszky-krankheit.
Thomson et al. Foot and Mouth Disease in Southern Africa: Re-evaluation of the approach to control
Madkey et al. Journal of Contemporary Medicine and Dentistry
Klaring et al. Mathematical Models for the Spread and Control of Foot‐and‐Mouth Disease During the 1973 Epidemic in Austria
Whitaker-Dowling et al. A new intranasal, modified-live virus vaccine for equine H3N8 influenza
NO20014372D0 (no) Isolering og delvis karakterisering av en ny antiprokferativ komponent fra humane leukocytter
TH62279A (th) วิธีการและวัคซีนสำหรับการจัดเตรียมการป้องกันในไข่ต่อต้านเทอร์คีไรโนทราคีไอติส
Damrongwatanapokin Foot-and-mouth disease: potential mechanism for prevention.
McNulty et al. Inactivated avian influenza neuraminidase-specific vaccines in chickens

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: UNIVERSITY OF PITTSBURGH, PITTSBURGH, PA., US

8327 Change in the person/name/address of the patent owner

Owner name: UNIVERSITY OF PITTSBURGH OF THE COMMONWEALTH S, US

8364 No opposition during term of opposition